Award-winning researcher and FCLV founder Dr. Shapiro has long been one of America’s leading forces advancing the science and practice of reproductive endocrinology. His lifelong commitment to research and innovation and his friendly and caring bedside manner have helped make our top fertility center an Oasis of Hope for people seeking to overcome infertility and grow their families.
Dr. Shapiro’s research background and long-standing interest in making IVF safer and more effective have led to many innovations. He was one of the first physicians to perform and report on blastocyst transfer in the United States. Blastocyst transfer is a procedure allowing the transfer of fewer embryos into the uterus while maintaining high pregnancy rates and reducing the risk of high-order multiple pregnancies (triplets and greater). He received a research award for this work.
Bruce Shapiro MD was also instrumental in developing techniques for post-thaw extended culture (PTEC) following fertilized oocyte cryopreservation demonstrating the importance of embryo-endometrial synchrony for implantation. He received another research award for this work.
Dr. Shapiro was among the first in the world to standardize the use of GnRH agonist triggers in high responders undergoing ovarian stimulation. This practice virtually eliminates ovarian hyperstimulation syndrome (OHSS). His innovations also include the combination of GnRH agonist with low-dose hCG to realize the benefits of each trigger agent. This work has allowed patients who have had previous IVF failures and/or OHSS to have a greater likelihood of conceiving and fewer complications.
